Gilead Sciences Inc. Canadian Depositary Receipt (GILD)
TSX
Closed
Oct 9, 2026
Day's Range
30.1752 wk Range
23.97Overview - GILD - Gilead Sciences Inc. Canadian Depositary Receipt
Key Statistics
Valuation
Enterprise Value
261.22B
P/E (Trailing)
‪17.00‬
PEG Ratio
‪-0.02‬
Price / Sales (TTM)
‪8.28‬
Price / Book
‪20.42‬
EV / EBITDA
‪17.63‬
Profitability
Gross Margin
‪79.76%‬
Profit Margin
‪78.82%‬
Operating Margin
‪36.75%‬
Return on Assets
‪14.41%‬
Return on Equity
‪37.62%‬
Ownership
Shares Outstanding
1.24B
Price stats
50-Day Avg
‪28.95‬
200-Day Avg
‪27.97‬
Dividends
Frequency
Quarterly
Market Cap - GILD - Gilead Sciences Inc. Canadian Depositary Receipt
Peers - GILD - Gilead Sciences Inc. Canadian Depositary Receipt
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on TSX.
- GILDTSXGilead Sciences Inc. Canadian Depositary Receipt243.85BMarket Cap+15.67%52-week change17.00P/E (Trailing)‪78.82%‬Profit Margin
- LLYTSXEli Lilly CDR1.45TMarket Cap+37.24%52-week change37.05P/E (Trailing)‪83.04%‬Profit Margin
- ABBVTSXAbbVie Inc. CDR640.88BMarket Cap+13.80%52-week change69.30P/E (Trailing)‪70.23%‬Profit Margin
- JNJTSXJohnson & Johnson630.04BMarket Cap+26.98%52-week change30.25P/E (Trailing)‪21.48%‬Profit Margin
- ROGTSXRoche Holding AG American Depositary Receipt524.02BMarket Cap+20.55%52-week change22.31P/E (Trailing)‪73.72%‬Profit Margin
- MRKTSXMerck & Co., Inc.509.66BMarket Cap+46.01%52-week change118.14P/E (Trailing)‪74.80%‬Profit Margin
- AMGNTSXAmgen Inc. Canadian Depositary Receipt304.51BMarket Cap+18.18%52-week change24.46P/E (Trailing)‪67.24%‬Profit Margin
Profile Summary - GILD - Gilead Sciences Inc. Canadian Depositary Receipt
About
Gilead Sciences Inc. Canadian Depositary Receipt is a Canadian-listed security that provides exposure to Gilead Sciences Inc., a global biopharmaceutical company headquartered in Foster City, California. Through this Canadian Depositary Receipt structure, investors can access the economic performance of Gilead…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
